Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix® is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system. Aortix™ is currently in the research and development phase and is not available for sale in any country. (Caution: investigational device. Limited by federal law to investigational use.)
| Website | https://www.procyrion.com |
| Revenue | $7.5 million |
| Employees | 31 (19 on RocketReach) |
| Founded | 2005 |
| Address | 3900 Essex Lane, Houston, Texas 77030, US |
| Phone | +1 713-579-9227 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+22 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Health Care, Surgical Devices, Manufacturing, Medical, Other Devices and Supplies, Medical Device |
| Web Rank | 4 Million |
| Keywords | Heart Failure Treatment, Catheter Based Therapies, Medical Device Technology, Innovative Medical Devices, Cardiovascular Devices |
| Competitors | Celsion Corporation, Thermo Fisher Scientific, Cardiovascular Systems, Inc., AstraZeneca, Siemens, Boston Scientific, Medtronic, Edwards Lifesciences, Abbott, Johnson & Johnson +44 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Procyrion, Inc. employee's phone or email?
The Procyrion, Inc. annual revenue was $7.5 million in 2026.
Eric Fain is the President and CEO of Procyrion, Inc..
19 people are employed at Procyrion, Inc..
Procyrion, Inc. is based in Houston, Texas.
The NAICS codes for Procyrion, Inc. are [33, 339].
The SIC codes for Procyrion, Inc. are [38, 384].